$BWV News
Last published 2y ago
- 2y agoBWVOnconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to ShareholdersGlobeNewswireCINCINNATI, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Onconetix, Inc., (NASDAQ:BWV) ("Onconetix" or the "Company") today issued the following shareholder letter from the Company's Chief Executive Officer, Dr. Neil
- 2y agoBWVONCOBlue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™GlobeNewswireCINCINNATI, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (NASDAQ:BWV) ("BWB" or the "Company") today announced the acquisition of Proteomedix AG, a private, commercial-stage diagnostics oncology
- 3y agoBWVBlue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology CompanyGlobeNewswireCINCINNATI, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (NASDAQ:BWV) ("BWB" or the "Company"), today announced the execution of a non-binding term sheet regarding the acquisition of a private
- 3y agoBWVBlue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1)GlobeNewswireCINCINNATI, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (NASDAQ:BWV) ("BWB" or the "Company") today announced that it has received a letter from the Nasdaq Stock Market, LLC ("Nasdaq")
- 3y agoBWVBlue Water Biotech Issues Letter to ShareholdersGlobeNewswireCINCINNATI, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (NASDAQ:BWV) ("BWB" or the "Company") today issued the following shareholder letter from the Company's Chief Executive Officer Dr. Neil
- 3y agoBWVBlue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFOGlobeNewswireCINCINNATI, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (NASDAQ:BWV), which is focused on developing and commercializing transformational therapies to address significant global health challenges, today
- 3y agoBWVBlue Water Biotech, Inc. Announces Notification From Nasdaq Related to Delayed Quarterly Report on Form 10-QGlobeNewswireCINCINNATI, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. ("Blue Water" or the "Company"), a biotechnology and pharmaceutical company spanning multiple sectors, today announced that it received a
- 3y agoBWVBlue Water Biotech and Copay Consultants Collaborate to Build Copay Assistance Programs for Blue Water's Commercial ProductsGlobeNewswireCINCINNATI, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. ("Blue Water" or the "Company"), a biotechnology and pharmaceutical company spanning multiple sectors, today announced the signing of an agreement
- 3y agoBWVBlue Water Biotech Announces Closing of Warrant Exercise and Issuance of New Warrants in A Private Placement For $2.7 Million Gross ProceedsGlobeNewswireCINCINNATI, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. ("Blue Water" or the "Company") (NASDAQ:BWV), today announced the closing of its previously announced exercise of certain existing warrants to
- 3y agoBWVBlue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI®GlobeNewswireCINCINNATI, July 25, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. ("Blue Water" or the "Company") (NASDAQ:BWV), a biotechnology and pharmaceutical company focused on developing and commercializing transformational
- 3y agoBWVBlue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch ActivitiesGlobeNewswireCINCINNATI, July 17, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. ("Blue Water" or the "Company") (NASDAQ:BWV), a biotechnology and pharmaceutical company focused on developing and commercializing transformational
- 3y agoBWVBlue Water Biotech Teams with Advantage Point Solutions to Provide Healthcare Payer Coverage SupportGlobeNewswireCINCINNATI, July 11, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. ("Blue Water" or the "Company") (NASDAQ:BWV), a biotechnology and pharmaceutical company focused on developing and commercializing transformational
- 3y agoBWVBlue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved ProductsGlobeNewswireCINCINNATI, July 06, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. ("Blue Water" or the "Company") (NASDAQ:BWV), a biotechnology and pharmaceutical company focused on developing and commercializing transformational
- 3y agoBWVBlue Water Biotech Teams with BFW Advertising to Market and Advertise Commercial Product PortfolioGlobeNewswireCINCINNATI, July 06, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. ("Blue Water" or the "Company") (NASDAQ:BWV), a biotechnology and pharmaceutical company focused on developing and commercializing transformational
- 3y agoBWVBlue Water Biotech Announces Preclinical Data Supporting Immunogenicity of Novel Monkeypox Vaccine Utilizing Norovirus Virus-Like Particle PlatformGlobeNewswireCINCINNATI, Ohio, June 28, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. ("Blue Water" or the "Company") (NASDAQ:BWV), a biotechnology and pharmaceutical company spanning multiple sectors, today announced
- 3y agoBWVBlue Water Biotech Collaborates with IQVIA to Build Medical Sales Representative Team to Market Commercial Product PortfolioGlobeNewswireCINCINNATI, June 21, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. ("Blue Water" or the "Company") (NASDAQ:BWV), a biotechnology and pharmaceutical company spanning multiple sectors, today announced plans to
- 3y agoBWVBlue Water Biotech Expands Commercial Portfolio by Acquiring Six FDA-Approved Drugs Across Various Treatment AreasGlobeNewswireCINCINNATI, Ohio, June 14, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (NASDAQ:BWV), a biotechnology company spanning multiple sectors, today announced the signing of an Asset Purchase Agreement (the "Agreement")
- 3y agoBWVBlue Water Biotech Reports First Quarter 2023 Financial Results and Recent Business HighlightsGlobeNewswireCINCINNATI, May 12, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. ("Blue Water" or the "Company"), a biotechnology company spanning multiple sectors, today announced its financial results for the quarter ended
- 3y agoBWVBlue Water Biotech to Present Corporate Overview and ENTADFI® Launch Plan at the JMP Securities Life Sciences Conference in New York, NYGlobeNewswireCINCINNATI, May 10, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. ("Blue Water" or the "Company"), a biopharmaceutical company developing transformational therapies to address significant global health challenges,
- 3y agoBWVBlue Water Biotech Appoints Board-Certified Urologist Jay Newmark, M.D., MBA as Chief Medical OfficerGlobeNewswireCINCINNATI, April 26, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. ("Blue Water" or the "Company"), a biotechnology company spanning multiple sectors, today announced the appointment of Jay Newmark, M.D., MBA as
- 3y agoBWVBlue Water Biotech to Participate in the American Urological Association Annual Meeting 2023 to Promote Benign Prostatic Hyperplasia Treatment ENTADFI®GlobeNewswireCINCINNATI, April 25, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. ("Blue Water" or the "Company"), a biotechnology company spanning multiple sectors, today announced that Blue Water management will attend the
- 3y agoBWVBlue Water Vaccines Announces Corporate Name Change to Blue Water Biotech in Connection with Transition into Commercial-Stage Biotechnology CompanyGlobeNewswireCINCINNATI, April 24, 2023 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("Blue Water" or the "Company"), a biopharmaceutical company developing transformational therapies to address significant global health
- 3y agoBWVBlue Water Announces Acquisition of ENTADFI®, an FDA-Approved Benign Prostatic Hyperplasia AssetGlobeNewswireAcquisition Transforms the Company into a Broader Pharmaceutical Company Spanning Multiple Sectors Company Announces Corporate Name Change to Underscore Broader Focus Company to Host a Conference call Today, April
- 3y agoBWVVERUVeru Sells ENTADFI® Business for $20 Million Plus up to an Additional $80 Million from Sales MilestonesGlobeNewswireMIAMI, FL, April 20, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a biopharmaceutical company focused on developing novel medicines for oncology and SARS-CoV-2 and other viral ARDS-related diseases, today
- 3y agoBWVBlue Water Vaccines Announces Signing of Sponsored Research Agreement with The University of Texas Health Science Center at San Antonio to Initiate Non-Human Primate Study for Live Attenuated, Orally Delivered Chlamydia VaccineGlobeNewswireCINCINNATI, April 12, 2023 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing transformational vaccines to address significant global
- 3y agoBWVBlue Water Vaccines Reports Year 2022 Financial Results and Recent Business HighlightsGlobeNewswireCINCINNATI, March 09, 2023 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), today announced its financial results for the fiscal year ended December 31, 2022 and provided
- 3y agoBWVBlue Water Vaccines Appoints Seasoned Commercial Operations Leader Frank Jaeger as Senior Vice President of Marketing and Business DevelopmentGlobeNewswireCINCINNATI, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), today announced the appointment of Frank Jaeger, seasoned commercial operations and business
- 3y agoBWVBlue Water Vaccines Announces Partnership with AbVacc for Joint Development of Novel Monkeypox and Marburg Vaccine CandidatesGlobeNewswireCINCINNATI, Ohio, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing transformational vaccines to address significant
- 3y agoBWVBlue Water Vaccines Announces Appointment of Seasoned Public Market and Private Equity Investment Leader Timothy Ramdeen to Board of DirectorsGlobeNewswireCINCINNATI, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing transformational vaccines to address significant global
- 3y agoBWVBlue Water Vaccines to Present at Biotech Showcase 2023 During the 41st Annual J.P. Morgan Healthcare Conference Week in San FranciscoGlobeNewswireCINCINNATI, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing transformational vaccines to address significant global
- 3y agoBWVBlue Water Vaccines Announces Institutional Research Coverage by Two Notable Healthcare-Focused Wall Street Banks, Receives "Buy" Rating From BothGlobeNewswireCINCINNATI, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing transformational vaccines to address significant global
- 3y agoBWVBlue Water Vaccines Organizes Key Opinion Leader Event to Discuss Unmet Need for Acute Otitis Media and Pneumonia Vaccine and Its Streptococcus pneumoniae Vaccine CandidateGlobeNewswireCINCINNATI, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or the "Company") a biopharmaceutical company developing transformational vaccines to address significant global
- 3y agoBWVBlue Water Vaccines to Present Update on Novel, Live Attenuated, Intranasally Delivered Streptococcus pneumoniae Vaccine to Prevent Acute Otitis Media, Pneumococcal Pneumonia, and Invasive Pneumococcal Disease at the World Vaccine & Immunotherapy Congress West Coast 2022GlobeNewswireCINCINNATI, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), today announced that Ali Fattom, Ph.D., will present at the World Vaccine & Immunotherapy
- 3y agoBWVBlue Water Vaccines Announces Exclusive, Global License Agreement for Chlamydia Vaccine Candidate Development from The University of Texas Health San AntonioGlobeNewswireCINCINNATI, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or "the Company") a biopharmaceutical company developing transformational vaccines to address significant global
- 4y agoBWVBlue Water Vaccines Reports Third Quarter 2022 Financial Results and Recent Business Highlights; Announces 5 Million Share Repurchase ProgramGlobeNewswireClosed private placement in August 2022, with net proceeds of approximately $8.7 millionAnnounced plans to evaluate efficacy of BWV-201 for protection against non-invasive pneumococcal pneumonia in children and
- 4y agoBWVBlue Water Vaccines Announces Appointment of Vuk Jeremić, Previous Chair of the Council of Europe's Committee of Ministers and Previous President of the United Nations General Assembly, to Its Board of DirectorsGlobeNewswireCINCINNATI, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing transformational vaccines to address significant global
- 4y agoBWVBlue Water Vaccines Announces Plans to Evaluate Efficacy of Streptococcus pneumoniae Vaccine Candidate Against Pneumococcal Pneumonia at the World Vaccine Congress in BarcelonaGlobeNewswireCINCINNATI, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing transformational vaccines to address significant global
- 4y agoBWVBlue Water Vaccines to Present at World Vaccine Congress Europe 2022GlobeNewswireCINCINNATI, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced
- 4y agoBWVBlue Water Vaccines to Present In Person and via Webcast at H.C. Wainwright's 24th Annual Global Investment Conference in New York, NYGlobeNewswireCINCINNATI, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or "the Company") a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced
- 4y agoAKANAPMBWVGNS+6Notice to Boustead Securities Customers Who Purchased IPOsGlobeNewswireNEW YORK, Aug. 31, 2022 (GLOBE NEWSWIRE) -- The securities law firm of KlaymanToskes is interested in speaking with current and former customers of Boustead Securities that participated in IPOs offered through the company. Boustead offered IPOs that ha
- 4y agoBWVBlue Water Vaccines to Present at H.C. Wainwright's 24th Annual Global Investment Conference in New York, NYGlobeNewswireCINCINNATI, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or "the Company") a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced t
- 4y agoBWVBlue Water Vaccines to Present at The Universal Influenza Vaccines 2022 Conference in Oxford, United KingdomGlobeNewswireCINCINNATI, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or "the Company") a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced t
- 4y agoBWVBlue Water Vaccines Announces Appointment of Retired Deloitte Consulting Senior Managing Director Simon Tarsh to Board of DirectorsGlobeNewswireCINCINNATI, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or "the Company"), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced
- 4y agoBWVBlue Water Vaccines Announces Exploration of Its Virus-Like Particle (VLP) Platform for Use in Monkeypox Vaccine CandidateGlobeNewswireCINCINNATI, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or "the Company"), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced
- 4y agoBWVBlue Water Vaccines Reports Second Quarter 2022 Financial Results and Recent Business HighlightsGlobeNewswireClosed private placement in April 2022, with net proceeds of approximately $6.9 million Signed multiple strategic agreements and collaborations to further vaccine candidate research, development, and manufacturing $22.2 million in cash as of June 30,
- 4y agoBWVBlue Water Vaccines Announces Closing of $10 Million Private Placement Priced At-the-Market Under Nasdaq RulesGlobeNewswireCINCINNATI, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced
- 4y agoBWVBlue Water Vaccines Announces $10 Million Private Placement Priced At-the-Market under Nasdaq RulesGlobeNewswireCINCINNATI, Ohio, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or "the Company"), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today anno
- 4y agoBWVCRXTOGENOragenics Appoints Seasoned Vaccine Executive Kimberly Murphy as President and Chief Executive OfficerBusiness WireOragenics, Inc. (NYSE:OGEN) ("Oragenics" or the "Company"), a biotech company dedicated to fighting infectious diseases including coronaviruses, announces the appointment of Ms. Kimberly M. Murphy, member of the Board of Directors, as President and Chie
- 4y agoBWVBlue Water Vaccines to Present at the JMP Securities Life Science ConferenceGlobeNewswireCINCINNATI, June 06, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or "the Company"), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced
- 4y agoBWVBlue Water Vaccines Announces Sponsored Research Agreement Amendment to Continue Funding Universal Influenza Vaccine Development at The University of OxfordGlobeNewswireCINCINNATI, May 31, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or "the Company") a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced th